ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS

被引：0
|
作者：
KALISH, V [1 ]
KALDOR, S [1 ]
SHETTY, B [1 ]
TATLOCK, J [1 ]
DAVIES, J [1 ]
HAMMOND, M [1 ]
DRESSMAN, B [1 ]
FRITZ, J [1 ]
APPELT, K [1 ]
REICH, S [1 ]
MUSICK, L [1 ]
WU, BW [1 ]
SU, K [1 ]
机构：
[1] ELI LILLY & CO,INDIANAPOLIS,IN 46285
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 1995年 / 30卷
关键词：
HIV PROTEASE INHIBITORS; STRUCTURE-BASED DRUG DESIGN; AG1343; AIDS;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：S201 / S214
页数：14
相关论文
共 50 条
  • [1] STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASE
    WLODAWER, A
    ERICKSON, JW
    ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 : 543 - 585
  • [2] Structure-based design of nonpeptidic HIV protease inhibitors: The sulfonamide-substituted cyclooctylpyranones
    Skulnick, HI
    Johnson, PD
    Aristoff, PA
    Morris, JK
    Lovasz, KD
    Howe, WJ
    Watenpaugh, KD
    Janakiraman, MN
    Anderson, DJ
    Reischer, RJ
    Schwartz, TM
    Banitt, LS
    Tomich, PK
    Lynn, JC
    Horng, MM
    Chong, KT
    Hinshaw, RR
    Dolak, LA
    Seest, EP
    Schwende, FJ
    Rush, BD
    Howard, GM
    Toth, LN
    Wilkinson, KR
    Kakuk, TJ
    Johnson, CW
    Cole, SL
    Zaya, RM
    Zipp, GL
    Possert, PL
    Dalga, RJ
    Zhong, WZ
    Williams, MG
    Romines, KR
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (07) : 1149 - 1164
  • [3] Application of EMBM to Structure-Based Design of Warheads for Protease Inhibitors
    Traube, Tamar
    Shokhen, Michael
    Albeck, Amnon
    MOLECULAR INFORMATICS, 2014, 33 (01) : 36 - 42
  • [4] Development of a protease production platform for structure-based drug design
    Fox, Ted
    Brennan, Debra
    Austen, Douglas A.
    Swalley, Susanne E.
    Coll, Joyce T.
    Raybuck, Scott A.
    Chambers, Stephen P.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (05) : 439 - 445
  • [5] Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors
    Namoto, Kenji
    Sirockin, Finton
    Sellner, Holger
    Wiesmann, Christian
    Villard, Frederic
    Moreau, Robert J.
    Valeur, Eric
    Paulding, Stephanie C.
    Schleeger, Simone
    Schipp, Kathrin
    Loup, Joachim
    Andrews, Lori
    Swale, Ryann
    Robinson, Michael
    Farady, Christopher J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 906 - 909
  • [6] Structure-based drug design of selective 5'-nucleotidases inhibitors
    Pachl, Petr
    Brynda, Jiri
    Rosenberg, Ivan
    Fabry, Milan
    Rezacova, Pavlina
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2011, 67 : C227 - C228
  • [7] Structure-based drug design of novel peptidomimetic cellulose derivatives as HCV-NS3 protease inhibitors
    Saleh, Noha A.
    Elshemey, Wael M.
    LIFE SCIENCES, 2017, 187 : 58 - 63
  • [8] Fragment screening and structure-based design of adrenaline synthesis inhibitors
    Martin, Jennifer L.
    Drinkwater, Nyssa
    Gee, Christine L.
    McLeish, Michael J.
    Grunewald, Gary L.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : C344 - C344
  • [9] PROTEIN STRUCTURE-BASED DESIGN OF POTENT ORALLY BIOAVAILABLE, NONPEPTIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE
    REICH, SH
    MELNICK, M
    DAVIES, JF
    APPELT, K
    LEWIS, KK
    FUHRY, MA
    PINO, M
    TRIPPE, AJ
    NGUYEN, D
    DAWSON, H
    WU, BW
    MUSICK, L
    KOSA, M
    KAHIL, D
    WEBBER, S
    GEHLHAAR, DK
    ANDRADA, D
    SHETTY, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3298 - 3302
  • [10] Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin
    Hartman, Alwin M.
    Mondal, Milon
    Radeva, Nedyalka
    Klebe, Gerhard
    Hirsch, Anna K. H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (08): : 19184 - 19194
12345